Intra-Cellular Therapies entered the industry of Research Services in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 5417115, which describes it as a Research Services. For further clarification, the SIC classifies this business under the code 8732 and described it as a Research Services. The business provides service to the B2B market.
To acquire more information, please contact Sharon Mates, Chief Executive Officer by calling (212) 923-3344 during business hours. You can also write to the business’ Single Location at 3960 Broadway, New York City, New York NY 10032. You can also visit the company’s website at intracellulartherapies.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Intra-Cellular Therapies |
| Representative: | Sharon Mates, Chief Executive Officer |
| Place of Business: | 3960 Broadway, New York City, NY 10032 |
| Contact Number: | (212) 923-3344 |
| Website: | intracellulartherapies.com |
| Type of Service: | Research Services |
| SIC Number: | 8732 |
| NAICS Number: | 5417115 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2002 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Intra-Cellular Therapies is a company operating from New York, New York providing professional Research Services and relevant B2B variables. It was founded in 2002 and registered with the SIC code 8732 as Research Services, and with the NAICS code 5417115 as Research Services.
With a current employee count of 1 to 4, Intra-Cellular Therapies has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Sharon Mates, Chief Executive Officer at (212) 923-3344 for related queries, or to locate its Single Location using the coordinates 40.83982,-73.94048.
The Single Location can also be found at the street address 3960 Broadway in New York City, New York 10032 and can be engaged online through the company website at intracellulartherapies.com, the company Twitter , and Facebook page .